Ivermectin in dermatology: why it 'mite' be useless against COVID-19.
作者信息
Roche D, O'Connor C, Murphy M
机构信息
Department of Dermatology, South Infirmary Victoria University Hospital, Cork, Ireland.
Department of Medicine, University College Cork, Cork, Ireland.
出版信息
Clin Exp Dermatol. 2021 Oct;46(7):1327-1328. doi: 10.1111/ced.14704. Epub 2021 Jun 26.
Abstract
摘要
相似文献
1
Ivermectin in dermatology: why it 'mite' be useless against COVID-19.伊维菌素在皮肤病学中的应用：为何它可能对新冠病毒无效。
Clin Exp Dermatol. 2021 Oct;46(7):1327-1328. doi: 10.1111/ced.14704. Epub 2021 Jun 26.
2
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?从羟氯喹到伊维菌素：抗寄生虫药物的抗病毒特性如何对抗 SARS-CoV-2？
J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taab005.
3
Comparative therapeutic effect of moxidectin, doramectin and ivermectin on psoroptes mites infestation in buffalo (Bubalus bubalis).莫西菌素、多拉菌素和伊维菌素对水牛（水牛属）痒螨感染的比较治疗效果。
Trop Anim Health Prod. 2009 Oct;41(7):1505-11. doi: 10.1007/s11250-009-9340-9. Epub 2009 Apr 4.
4
Efficacy of selamectin in the treatment of nasal mite (Pneumonyssoides caninum) infection in dogs.塞拉菌素治疗犬鼻螨（犬肺刺螨）感染的疗效。
J Am Anim Hosp Assoc. 2004 Sep-Oct;40(5):400-4. doi: 10.5326/0400400.
5
Ivermectin in COVID-19: What do we know?伊维菌素与新冠病毒：我们了解些什么？
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1921-1922. doi: 10.1016/j.dsx.2020.09.027. Epub 2020 Sep 28.
6
Pneumonyssoides species infestation in two Pekingese dogs in the UK.英国两只北京犬感染肺刺螨属物种
J Small Anim Pract. 2008 Feb;49(2):107-9. doi: 10.1111/j.1748-5827.2007.00500.x.
7
A demodicosis case which responded to systemic ivermectin.
Eur J Dermatol. 2009 Mar-Apr;19(2):189-90. doi: 10.1684/ejd.2008.0613. Epub 2009 Jan 20.
8
Case series: Efficacy of a formulation containing selamectin and sarolaner against naturally acquired mite infestations (Demodex sp., Ornithonyssus bacoti) in degus (Octodon degus).病例系列：含有塞拉菌素和沙罗菌素的配方对（狄氏副绒鼠螨，巴氏禽刺螨）自然感染的地松鼠（Octodon degus）螨虫感染的疗效。
Vet Parasitol. 2021 May;293:109430. doi: 10.1016/j.vetpar.2021.109430. Epub 2021 Apr 19.
9
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?广谱宿主导向药物伊维菌素作为 SARS-CoV-2 的抗病毒药物？
Biochem Biophys Res Commun. 2021 Jan 29;538:163-172. doi: 10.1016/j.bbrc.2020.10.042. Epub 2020 Oct 21.
10
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19.关于将伊维菌素重新用于治疗新冠肺炎的药代动力学考量
Br J Clin Pharmacol. 2021 Mar;87(3):1589-1590. doi: 10.1111/bcp.14476. Epub 2020 Jul 17.
引用本文的文献
1
Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry.使用液相色谱-串联质谱法在体积吸收微采样中进行伊维菌素定量方法的开发与验证
Heliyon. 2024 Apr 15;10(8):e29606. doi: 10.1016/j.heliyon.2024.e29606. eCollection 2024 Apr 30.
本文引用的文献
1
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.伊维菌素对轻症 COVID-19 成人症状缓解时间的影响：一项随机临床试验。
JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.
2
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
3
Shedding light on the myths of ultraviolet radiation in the COVID-19 pandemic.揭示新冠疫情中紫外线辐射的误解
Clin Exp Dermatol. 2021 Jan;46(1):187-188. doi: 10.1111/ced.14456. Epub 2020 Oct 8.
4
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
Zotero 插件